284 related articles for article (PubMed ID: 3511524)
1. [New findings on the pathogenesis of diabetes mellitus].
Keller U
Schweiz Med Wochenschr; 1986 Jan; 116(3):66-71. PubMed ID: 3511524
[TBL] [Abstract][Full Text] [Related]
2. [Latent autoimmune diabetes in adults(LADA): part of the clinical spectrum of type-1 diabetes mellitus of autoimmune origin].
Pánczél P; Hosszúfalusi N; Bornemisza B; Horváth L; Jánoskuti L; Füst G; Rajczy K; Vatay A; Prohászka Z; Madácsy L; Luczay A; Blatniczky L; Halmos T; Körner A; Szilvási I; Romics L
Orv Hetil; 2001 Nov; 142(46):2571-8. PubMed ID: 11770176
[TBL] [Abstract][Full Text] [Related]
3. [Detection of antibodies against pancreatic islet cells in clinical practice].
Pánczél P; Külkey O; Luczay A; Bornemisza B; Illyés G; Halmos T; Baranyi E; Blatniczky L; Mészáros J; Kerényi Z; Geró L; Tamás G; Hosszúfalusi N; Horváth L; Madácsy L; Romics L
Orv Hetil; 1999 Nov; 140(48):2695-701. PubMed ID: 10645715
[TBL] [Abstract][Full Text] [Related]
4. [Effects of xenotransplantation of pancreatic islet cells on the immune status of patients with diabetes mellitus].
Morozov IuI; Kirdeĭ EG; Kim AIu
Klin Med (Mosk); 1995; 73(2):32-4. PubMed ID: 7609413
[TBL] [Abstract][Full Text] [Related]
5. Genes and engineered cells as drugs for type I and type II diabetes mellitus therapy and prevention.
Giannoukakis N; Pietropaolo M; Trucco M
Curr Opin Investig Drugs; 2002 May; 3(5):735-51. PubMed ID: 12090547
[TBL] [Abstract][Full Text] [Related]
6. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis.
Bottazzo GF; Dean BM; McNally JM; MacKay EH; Swift PG; Gamble DR
N Engl J Med; 1985 Aug; 313(6):353-60. PubMed ID: 3159965
[TBL] [Abstract][Full Text] [Related]
7. C. L. Oakley lecture (1987). The pathogenesis of beta cell destruction in type I (insulin-dependent) diabetes mellitus.
Foulis AK
J Pathol; 1987 Jul; 152(3):141-8. PubMed ID: 3309229
[TBL] [Abstract][Full Text] [Related]
8. The Unitarian Hypothesis for the aetiology of diabetes mellitus.
Morrison EY; Ragoobirsingh D; Peter SA
Med Hypotheses; 2006; 67(5):1115-20. PubMed ID: 16806731
[TBL] [Abstract][Full Text] [Related]
9. [C-peptide as the decisive factor for classification of type 1 diabetes mellitus and type 2 diabetes mellitus].
Perusicová J; Bárová H; Hill M; Masek Z
Vnitr Lek; 2002 Jun; 48(6):490-9. PubMed ID: 12132349
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune diabetes in adults: lessons from the UKPDS.
Desai M; Clark A
Diabet Med; 2008 Aug; 25 Suppl 2():30-4. PubMed ID: 18717976
[TBL] [Abstract][Full Text] [Related]
11. [Diabetes mellitus in the elderly: a study on its clinical presentation, C-peptide reserve, and immunogenetic markers of insulin dependence].
Seclén Santisteban S; Alvarez Huamán RI; Chantres Antoranz MT; Serrano Ríos M
Rev Clin Esp; 1993 Mar; 192(4):162-8. PubMed ID: 8480059
[TBL] [Abstract][Full Text] [Related]
12. [The autoimmune mechanisms of the development of insulin-dependent diabetes mellitus].
Shishko PI
Ter Arkh; 1991; 63(6):l46-51. PubMed ID: 1948721
[No Abstract] [Full Text] [Related]
13. Cloned T cells from a recent onset IDDM patient reactive with insulin B-chain.
Schloot NC; Willemen S; Duinkerken G; de Vries RR; Roep BO
J Autoimmun; 1998 Apr; 11(2):169-75. PubMed ID: 9650096
[TBL] [Abstract][Full Text] [Related]
14. [Principles of immunotherapy in insulin-dependent diabetes mellitus].
Bretzel RG
Wien Klin Wochenschr; 1988 Jun; 100(13):435-42. PubMed ID: 3043913
[TBL] [Abstract][Full Text] [Related]
15. Immunological aspects of diabetes.
Cheţa D
Recenti Prog Med; 1990 Feb; 81(2):72-8. PubMed ID: 2195611
[TBL] [Abstract][Full Text] [Related]
16. [C-peptide determination in diabetics for the evaluation of insulin requirements].
Keller U; Pasquel M; Berger W
Schweiz Med Wochenschr; 1987 Feb; 117(6):187-92. PubMed ID: 3551060
[TBL] [Abstract][Full Text] [Related]
17. Promising new approaches.
Reasner CA
Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
[TBL] [Abstract][Full Text] [Related]
18. [Amylin as an additional possible pathogenic factor in NIDDM and the insulin resistance syndrome].
Hrnciar J
Vnitr Lek; 1996 Aug; 42(8):557-60. PubMed ID: 8967027
[TBL] [Abstract][Full Text] [Related]
19. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes).
Gerö L; Korányi L; Tamás G
Diabete Metab; 1983 Sep; 9(3):183-7. PubMed ID: 6360742
[TBL] [Abstract][Full Text] [Related]
20. Latent Autoimmune Diabetes in Adults: a case report.
Bermúdez V; Aparicio D; Colmenares C; Peñaranda L; Luti Y; Gotera D; Rojas J; Cabrera M; Reyna N; Velasco M; Israili ZH
Am J Ther; 2010; 17(3):284-7. PubMed ID: 20224323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
